Salutaris lands FDA OK for radionuclide brachytherapy

Ophthalmic medical device developer Salutaris Medical Devices has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its SMD-Sr90-DA radionuclide brachytherapy source.

Designed for use with a manual brachytherapy applicator system, the device is indicated for episcleral brachytherapy procedures, according to the company.

Page 1 of 462
Next Page